C260-2281 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-(3-{4-[(cyclopentylcarbamoyl)methyl]phenyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl)acetamide

C260-2281 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-(3-{4-[(cyclopentylcarbamoyl)methyl]phenyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl)acetamide
C260-2281 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-(3-{4-[(cyclopentylcarbamoyl)methyl]phenyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-2281
N-[2-(cyclohex-1-en-1-yl)ethyl]-2-(3-{4-[(cyclopentylcarbamoyl)methyl]phenyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-2281

Molecular Formula

C31H36N4O4 (C31 H36 N4 O4)

Compound Name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-(3-{4-[(cyclopentylcarbamoyl)methyl]phenyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl)acetamide

IUPAC name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-(3-{4-[(cyclopentylcarbamoyl)methyl]phenyl}-24-dioxo-1234-tetrahydroquinazolin-1-yl)acetamide

SMILES

O=C(Cc(cc1)ccc1N(C(c(cccc1)c1N1CC(NCCC2=CCCCC2)=O)=O)C1=O)NC1CCCC1

InChI

InChI=1S/C31H36N4O4/c36-28(33-24-10-4-5-11-24)20-23-14-16-25(17-15-23)35-30(38)26-12-6-7-13-27(26)34(31(35)39)21-29(37)32-19-18-22-8-2-1-3-9-22/h6-8,12-17,24H,1-5,9-11,18-21H2,(H,32,37)(H,33,36)

InChI Key

SUBOIIPZFJMNHX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14738513

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

528.65

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.843

Distribution Coefficient, logD

2.843

Water Solubility, LogSw

-3.66

Polar Surface Area

79.452

Acid Dissociation Constant (pKa)

15.47

Base Dissociation Constant (pKb)

4.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.90

C260-2281 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Regenerative Medicine Focused Library (23016 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C260-2281 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-2281?
Check Price and Availability of C260-2281, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-2281 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-2281
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-2281
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-2281 available by request